4.6 Article

High incidence and prevalence of MS in More and Romsdal County, Norway, 1950-2018

Journal

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1212/NXI.0000000000000713

Keywords

-

Funding

  1. More og Romsdal Hospital Trust
  2. Novartis Norge AS

Ask authors/readers for more resources

Objective To determine prevalence and longitudinal trends in incidence of MS in More and Romsdal County, Western Norway, from 1950 to 2018. Methods Retrospective longitudinal population-based observational study. All patients diagnosed, or living, with MS in More and Romsdal were identified as incident or prevalent cases from local, regional, and national sources. We compiled the data in the Norwegian Multiple Sclerosis Registry and Biobank and used the aggregated data set to calculate incidence and prevalence rates using population measures obtained from Statistics Norway. Results On January 1, 2018, the estimated prevalence was 335.8 (95% CI, 314.1-358.5) per 100,000 inhabitants, with a female:male ratio of 2.3. From 1950 through 2017, we observed a considerable (p< 0.001) increase in average annual incidence rates from 2.1 (95% CI, 1.3-3.3) to 14.4 (95% CI, 11.9-17.3) per 100,000. From 2005 through 2017, the incidence among women increased from 17.1 (95% CI, 14.0-20.7) to 23.2 (95% CI, 18.7-28.5) per 100,000, whereas the incidence among men declined from 10.3 (95% CI, 7.9-13.2) to 5.9 (95% CI, 3.4-8.8) per 100,000. Conclusion More and Romsdal County in Western Norway has the highest prevalence of MS reported in Norway. The incidence has steadily increased since 1950, and during the latest 15 years, we observed opposing trends in sex-specific incidence rates.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Clinical Neurology

Perinatal Depression and Anxiety in Women With Multiple Sclerosis A Population-Based Cohort Study

Karine Eid, Oivind Fredvik Torkildsen, Jan Aarseth, Heidi Oyen Flemmen, Trygve Holmoy, Aslaug Rudjord Lorentzen, Kjell-Morten Myhr, Trond Riise, Cecilia Simonsen, Cecilie Fredvik Torkildsen, Stig Wergeland, Johannes Sverre Willumsen, Nina oksendal, Nils Erik Gilhus, Marte-Helene Bjork

Summary: Women diagnosed with multiple sclerosis have an increased risk of perinatal depression, especially those diagnosed postpartum. Women with onset of MS symptoms within 5 years after pregnancy have an increased risk of both depression and anxiety during pregnancy.

NEUROLOGY (2021)

Article Clinical Neurology

Mortality and cause of death in multiple sclerosis in western Norway 1950-2021: a registry-based linkage study

Johannes Sverre Willumsen, Nina Grytten, Jan Aarseth, Tor Age Myklebust, Kjell-Morten Myhr, Rune Midgard

Summary: Excess mortality among persons with multiple sclerosis (pwMS) has declined during the past seven decades, possibly due to improved diagnostics, better symptomatic treatment, and access to disease-modifying treatments (DMTs).

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2022)

No Data Available